AmgenvsOmada Health

AMGN and OMDA stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$462.32

Value $249B

-0.72%
AMGN's page

Amgen (AMGN) has a market value of $249B and Omada Health (OMDA) $899M. Over the last year, with dividends, AMGN moved +41.1% and OMDA -27.7%. The P/E is 26.5 for AMGN and 64.1 for OMDA. Dividend yield: AMGN 2.15%, OMDA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$249B

    OMDA$899M

    AMGN is 277 times OMDA

  • Revenue, 12 months

    AMGN$38.9B

    OMDA$333M

    AMGN is 117 times OMDA

  • Net income, 12 months

    AMGN$9.4B

    OMDA$14M

    AMGN is 669 times OMDA

  • Operating margin

    AMGN32.4%

    OMDA2.1%

    30.3 points apart

  • ROIC

    AMGN16.2%

    OMDA2.3%

    13.9 points apart

  • P/E

    AMGN26.5

    OMDA64.1

    OMDA is 2.4 times AMGN

  • Dividend yield

    AMGN2.2%

    OMDA0.0%

    2.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+41.1%

OMDA-27.7%

100150DecFebAprJunAugOct
Returns by period
PeriodAMGNWith dividendsOMDAWith dividends
1 year since November 14, 2025+41.1%Price +37.3%-27.7%Price -27.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenOMDAOmada Health

Valuation

AMGNOMDA
Valuation
Price$462.32$14.49
Market value$249B$899M
Enterprise value (EV)$290B$656M
P/E26.564.1
P/E, 5-year median23.0–
P/B17.43.3
EV/EBIT23.095.5
Free cash flow yield3.8%3.1%

Results and growth

AMGNOMDA
Results and growth
Revenue, 12 months$38.9B$333M
Net income, 12 months$9.4B$14M
Free cash flow, 12 months$9.6B$28M
Earnings per share, 12 months$17.25$0.23
Revenue growth, year on year10.0%53.2%
Revenue growth a year, past+7.6%over 5 years+45.6%over 2 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNOMDA
Margins and returns on capital
Gross margin70.9%70.7%
Operating margin32.4%2.1%
Net margin24.1%4.2%
ROIC16.2%2.3%
ROE87.8%5.8%

Balance sheet

AMGNOMDA
Balance sheet
Cash$13.2B$243M
Total debt$54.0B$0
Net debt / EBITDA2.3-19.7
Interest cover4.8×22.4×

Dividends and buybacks

AMGNOMDA
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.2%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or OMDA

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Omada Health?

By market value, Amgen ($249B) is about 277.2 times Omada Health ($899M), at today's prices.

How did AMGN and OMDA stock do over the last 1 years?

Since November 14, 2025, AMGN's price moved +37.3% and OMDA's -27.7%. With dividends: AMGN +41.1% (+41.1% a year), OMDA -27.7% (-27.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or OMDA?

The dividend yield at today's price is 2.15% for Amgen and none for Omada Health. Over the last twelve months they paid $9.94 and – per share.

What is the P/E of AMGN and OMDA?

At today's price, the P/E is 26.5 for AMGN and 64.1 for OMDA. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Amgen or Omada Health?

Over the last twelve months, the net margin was 24.1% for Amgen and 4.2% for Omada Health, and the operating margin 32.4% and 2.1%. Revenue was $38.9B and $333M.

Which is the better investment, Amgen or Omada Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.